摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-carbethoxy-6-(1-methylethyl)-4(1H)-pyridinone | 134653-84-2

中文名称
——
中文别名
——
英文名称
3-carbethoxy-6-(1-methylethyl)-4(1H)-pyridinone
英文别名
Ethyl 6-(1-methylethyl)-4-oxo-1,4-dihydropyridine-3-carboxylate;ethyl 4-oxo-6-propan-2-yl-1H-pyridine-3-carboxylate
3-carbethoxy-6-(1-methylethyl)-4(1H)-pyridinone化学式
CAS
134653-84-2
化学式
C11H15NO3
mdl
——
分子量
209.245
InChiKey
ZIHYHYKUSNHKAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    3-carbethoxy-6-(1-methylethyl)-4(1H)-pyridinone三氯氧磷乙酸乙酯 、 Brine 、 Sodium sulfate-III异丙醇3-甲氧基丙胺三乙胺碳酸氢钠溶剂黄146 作用下, 以 三氯氧磷 为溶剂, 反应 18.0h, 以to give the object compound (263 mg)的产率得到Ethyl 4-[(3-methoxypropyl)amino]-6-(1-methylethyl)pyridine-3-carboxylate
    参考文献:
    名称:
    AMIDE COMPOUNDS AND USE OF THE SAME
    摘要:
    一种肾素抑制剂,包括一种由下式表示的化合物:其中每个符号如说明书中所定义,或其盐或前药。本发明的化合物具有优异的肾素抑制活性,因此可用作预防或治疗高血压、由高血压引起的各种器官损伤等的药剂。
    公开号:
    US20100324010A1
  • 作为产物:
    描述:
    ethyl (Z)-2-((dimethylamino)methylene)-3-oxobutanoate异丁酰氯正丁基锂 、 ammonium acetate 、 溶剂黄146六甲基二硅氮烷 作用下, 以23%的产率得到3-carbethoxy-6-(1-methylethyl)-4(1H)-pyridinone
    参考文献:
    名称:
    Generation and in situ acylation of enaminone anions: a convenient synthesis of 3-carbethoxy-4(1H)-pyridinones and -4-pyrones and related compounds
    摘要:
    Treatment of 2-[(dimethylamino)methylene]-3-oxobutanoates 9 or 10 with LiN(SiMe3)2 in the presence of RCOCl results in C-acylation. The resulting intermediate, without isolation, may be converted to 6-R 3-Carbethoxy-4-pyrones (e.g., 12) by H3O+ or to the corresponding pyridinones (e.g., 13) by NH4OAc. Typically, yields are 55-75% for R groups lacking acidic alpha or gamma protons and ca. 30% for R = Me2CH or MeCH = CH. Replacing 9 with MeCOC(= CHNMe2)SCH2Ph (from MeCOCH2SCH2Ph and Me2NCH(OMe)2 similarly affords 3(PhCH2S)-substituted products such as 29. Alkylation of the pyridinone anions produces mixtures of N- and O-substituted compounds, with the latter predominating; aminolysis of the isolated pyrones (R'NH2-HOAc, where R' = alkyl, Ar, HO, etc.) is the preferred route to the 1-R'-substituted pyridinones.
    DOI:
    10.1021/jo00016a028
点击查看最新优质反应信息

文献信息

  • AMIDE COMPOUNDS AND USE OF THE SAME
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP2202228B1
    公开(公告)日:2014-12-10
  • US8329691B2
    申请人:——
    公开号:US8329691B2
    公开(公告)日:2012-12-11
  • Generation and in situ acylation of enaminone anions: a convenient synthesis of 3-carbethoxy-4(1H)-pyridinones and -4-pyrones and related compounds
    作者:Stuart W. McCombie、William A. Metz、Dennis Nazareno、Bandarpalle B. Shankar、Jayaram Tagat
    DOI:10.1021/jo00016a028
    日期:1991.8
    Treatment of 2-[(dimethylamino)methylene]-3-oxobutanoates 9 or 10 with LiN(SiMe3)2 in the presence of RCOCl results in C-acylation. The resulting intermediate, without isolation, may be converted to 6-R 3-Carbethoxy-4-pyrones (e.g., 12) by H3O+ or to the corresponding pyridinones (e.g., 13) by NH4OAc. Typically, yields are 55-75% for R groups lacking acidic alpha or gamma protons and ca. 30% for R = Me2CH or MeCH = CH. Replacing 9 with MeCOC(= CHNMe2)SCH2Ph (from MeCOCH2SCH2Ph and Me2NCH(OMe)2 similarly affords 3(PhCH2S)-substituted products such as 29. Alkylation of the pyridinone anions produces mixtures of N- and O-substituted compounds, with the latter predominating; aminolysis of the isolated pyrones (R'NH2-HOAc, where R' = alkyl, Ar, HO, etc.) is the preferred route to the 1-R'-substituted pyridinones.
  • Amide compounds and use of the same
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US08329691B2
    公开(公告)日:2012-12-11
    A renin inhibitor comprising a compound represented by the formula: wherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof. The compound of the present invention has a superior renin inhibitory activity, and thus is useful as an agent for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension and the like.
    一种肾素抑制剂,包括由下式表示的化合物:其中每个符号如描述中所定义,或其盐或前药。本发明的化合物具有优异的肾素抑制活性,因此可用作预防或治疗高血压、由高血压引起的各种器官损伤等的药剂。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-